BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 36471376)

  • 1. Role of the Hippo pathway in liver regeneration and repair: recent advances.
    Pibiri M; Simbula G
    Inflamm Regen; 2022 Dec; 42(1):59. PubMed ID: 36471376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
    Konishi T; Schuster RM; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration.
    Lu L; Finegold MJ; Johnson RL
    Exp Mol Med; 2018 Jan; 50(1):e423. PubMed ID: 29303509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hippo-YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury.
    Deng F; Wu Z; Zou F; Wang S; Wang X
    Front Cell Dev Biol; 2022; 10():894737. PubMed ID: 35927987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis.
    Verboven E; Moya IM; Sansores-Garcia L; Xie J; Hillen H; Kowalczyk W; Vella G; Verhulst S; Castaldo SA; Algueró-Nadal A; Romanelli L; Mercader-Celma C; Souza NA; Soheily S; Van Huffel L; Van Brussel T; Lambrechts D; Roskams T; Lemaigre FP; Bergers G; van Grunsven LA; Halder G
    Gastroenterology; 2021 Feb; 160(3):847-862. PubMed ID: 33127392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade.
    Budel SJ; Penning MM; Penning LC
    Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration.
    Grijalva JL; Huizenga M; Mueller K; Rodriguez S; Brazzo J; Camargo F; Sadri-Vakili G; Vakili K
    Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G196-204. PubMed ID: 24875096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.
    Liu C; Cheng X; Chen J; Wang Y; Wu X; Tian R; Liu B; Ding X; Sun Q; Gong W
    Theranostics; 2019; 9(13):3840-3852. PubMed ID: 31281517
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communication.
    Liu K; Wehling L; Wan S; Weiler SME; Tóth M; Ibberson D; Marhenke S; Ali A; Lam M; Guo T; Pinna F; Pedrini F; Damle-Vartak A; Dropmann A; Rose F; Colucci S; Cheng W; Bissinger M; Schmitt J; Birner P; Poth T; Angel P; Dooley S; Muckenthaler MU; Longerich T; Vogel A; Heikenwälder M; Schirmacher P; Breuhahn K
    Cell Mol Life Sci; 2024 Mar; 81(1):115. PubMed ID: 38436764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis.
    Mooring M; Fowl BH; Lum SZC; Liu Y; Yao K; Softic S; Kirchner R; Bernstein A; Singhi AD; Jay DG; Kahn CR; Camargo FD; Yimlamai D
    Hepatology; 2020 May; 71(5):1813-1830. PubMed ID: 31505040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.
    Mia MM; Cibi DM; Abdul Ghani SAB; Song W; Tee N; Ghosh S; Mao J; Olson EN; Singh MK
    PLoS Biol; 2020 Dec; 18(12):e3000941. PubMed ID: 33264286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP and TAZ regulate Schwann cell proliferation and differentiation during peripheral nerve regeneration.
    Jeanette H; Marziali LN; Bhatia U; Hellman A; Herron J; Kopec AM; Feltri ML; Poitelon Y; Belin S
    Glia; 2021 Apr; 69(4):1061-1074. PubMed ID: 33336855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis.
    Boopathy GTK; Hong W
    Front Cell Dev Biol; 2019; 7():49. PubMed ID: 31024911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis.
    Bou Saleh M; Louvet A; Ntandja-Wandji LC; Boleslawski E; Gnemmi V; Lassailly G; Truant S; Maggiotto F; Ningarhari M; Artru F; Anglo E; Sancho-Bru P; Corlu A; Argemi J; Dubois-Chevalier J; Dharancy S; Eeckhoute J; Bataller R; Mathurin P; Dubuquoy L
    J Hepatol; 2021 Oct; 75(4):912-923. PubMed ID: 34129887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advances in the role of the Hippo-YAP/TAZ signaling pathway in primary liver cancer].
    Guo LW; Shao GL
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):878-880. PubMed ID: 29325286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.